Abstract
The production of substandard and fake drugs is a vast and underreported problem, particularly affecting poorer countries. Cockburn and colleagues argue that the pharmaceutical industry and governments must both take action
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Confidentiality
-
Drug Industry*
-
Economic Competition
-
Fraud*
-
Global Health
-
Government
-
Humans
-
Information Services*
-
Legislation, Drug
-
Patient Education as Topic
-
Security Measures